here was no new data. Except for "the FDA is re
Post# of 148184
Except for "the FDA is reviewing unblinded CD12 data".
And even Seethamraju's choice of words seems telling to me.
Seethamraju doesn't say "the FDA is reviewing the interim analysis."
Seethamraju says the "the FDA is reviewing unblinded data".
Read More: https://investorshangout.com/post/view?id=593...z6azZvEV9J
I had the impression the Dr was reading from a prepared script. If so it is not likely to be a slip of the tongue.